Physician profile
Gary Jacobs
NPI 1992772552
$2,299.38
in general payments reported to CMS, 2019-2025
15 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $929 · 2020: $272 · 2021: $168 · 2022: $252 · 2023: $346 · 2024: $134 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $789.17 | 2019-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| Biotissue Holdings INC. | $661.80 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $227.93 | 2020-2021 | |
| Glaukos Corporation | $212.29 | 2020-2023 | |
| Abbvie INC. | $106.30 | 2022-2025 | |
| Oyster Point Pharma, INC. | $66.33 | 2022-2024 | Tyrvaya, Ryzumvi |
| Horizon Therapeutics Plc | $51.85 | 2021-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $47.77 | 2023 | Vyzulta, Miebo |
| Harrow Eye, LLC | $29.46 | 2024 | Vevye |
| Ocular Therapeutix, INC. | $21.28 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $18.83 | 2021 | |
| Allergan, INC. | $16.45 | 2021 | |
| Rxsight INC | $15.52 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.